All lobbying filings

BLUEBIRD STRATEGIES

BLUEBIRD STRATEGIES filed a Q3 report for CELLTRION USA, INC. on October 16, 2026.

Lobbying for CELLTRION USA, INC. · Biopharmaceutical Company

All filings by BLUEBIRD STRATEGIES · Everything CELLTRION USA, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 16, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to CMS drug pricing, FDA drug regulations, biosimilar coverage and reimbursement

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.